We are in complete agreement. Johnbits problem is that he is looking over the entire history of GTCB as some kind of predictor of what will happen in the near future. That is clearly wrong as he doesn't grasp that rATIII approval in Europe changed the partnership terms or that the soon to be accomplished FDA submission will do the same, though not as much as the upcoming FDA approval.